Invention Grant
US08741921B2 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
有权
N-（咪唑烷-2-亚基） - 环四环[b]吡啶衍生物作为α2肾上腺素能受体的调节剂
![N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors](/docs/US/2014-06-03/US08741921B2/abs.jpg.600x600.jpg)
- Patent Title: N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
- Patent Title (中): N-（咪唑烷-2-亚基） - 环四环[b]吡啶衍生物作为α2肾上腺素能受体的调节剂
-
Application No.: US13945825Application Date: 2013-07-18
-
Publication No.: US08741921B2Publication Date: 2014-06-03
- Inventor: Santosh C. Sinha , Liming Wang , Ken Chow , Mohammed I. Dibas , Michael E. Garst
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D513/04 ; B65D25/20 ; C07D491/048
![N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors](/abs-image/US/2014/06/03/US08741921B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel N-(imidazolidin-2-ylidene)-heterocyclo penta[b]pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
Public/Granted literature
Information query
